MECOM have role in cell proliferation and is associated with chronic myeloid leukemia.[38] MEF2A is responsible for the insulin dependent glucose transporter GLUT4 expression and is downregulated in insulin deficient diabetes mellitus.[39]. Here, SLC2A4 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.